First Time Loading...

Beijing Hotgen Biotech Co Ltd
SSE:688068

Watchlist Manager
Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd
SSE:688068
Watchlist
Price: 30.19 CNY 5.01%
Updated: May 29, 2024

Beijing Hotgen Biotech Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Hotgen Biotech Co Ltd
Total Equity Peer Comparison

Comparables:
603259
300759
2269
300347
M
688114

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Hotgen Biotech Co Ltd
SSE:688068
Total Equity
¥3.4B
CAGR 3-Years
65%
CAGR 5-Years
74%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Total Equity
¥55.1B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Total Equity
¥12.6B
CAGR 3-Years
11%
CAGR 5-Years
35%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Total Equity
¥40.3B
CAGR 3-Years
25%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Total Equity
¥21B
CAGR 3-Years
9%
CAGR 5-Years
50%
CAGR 10-Years
39%
M
MGI Tech Co Ltd
SSE:688114
Total Equity
¥9.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Beijing Hotgen Biotech Co Ltd's Total Equity?
Total Equity
3.4B CNY

Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Total Equity amounts to 3.4B CNY.

What is Beijing Hotgen Biotech Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
74%

Over the last year, the Total Equity growth was 1%. The average annual Total Equity growth rates for Beijing Hotgen Biotech Co Ltd have been 65% over the past three years , 74% over the past five years .